Keragon, an AI-powered automation platform for healthcare, launches out of stealth with $3 million backing from Lifepoint Health

BOSTON, June 4, 2024 /PRNewswire/ — Keragon, an AI-powered HIPAA-compliant automation platform for healthcare, is officially launching out of stealth. It is the first no-code workflow automation platform designed specifically for the US healthcare industry. Currently, it is used by practices and clinics, fast-growing digital health startups, all the way up to hospitals & NASDAQ-listed companies, across the 50 states.

Keragon empowers healthcare professionals without a technical background to create powerful HIPAA-compliant automations.

The platform enables instant integration of various popular software used by healthcare practitioners (such as EHRs, healthcare CRMs, AI medical scribes, appointment scheduling & billing software). It has also built-in personalized AI assistants that fuel faster automations with less hassle.

Keragon empowers healthcare professionals without a technical background to create powerful automations that can save significant operational costs, improve clinical efficiency and ultimately improve patient care and reduce physician burnout. With over 100 pre-built healthcare integrations, multiple data transformation helpers and advanced error debugging capabilities, it is set to accelerate the digital transformation of healthcare.

Typical use cases include:

  • Breaking down the wall between the clinical & marketing teams, with a 2-way synchronization between the EHR and the marketing tool suite (CRM, forms, ads)
  • Reducing cognitive workload by triaging appointments booked in real-time, and then notifying only the relevant stakeholders in the communication tools of their choice (SMS, email, Slack, or Microsoft Teams)
  • Facilitating patient data interoperability between different healthcare software systems that currently don’t talk to each other

Keragon is on a mission to improve healthcare’s operational efficiency, while promoting the use of security best practices for all software vendors that handle sensitive patient data. It has been certified as both SOC 2 Type 2 & HIPAA compliant from external auditors.

The pre-seed funding round was co-led by Focal and Afore, followed by 25 Madison Health – Lifepoint Health.

About Keragon

Keragon is a no-code automation platform designed specifically for the healthcare industry. It allows healthcare professionals to easily connect all their healthcare software solutions, both homegrown and third-party, and build HIPAA-compliant workflows and automations without coding. The Keragon platform has over 100 pre-built integrations with leading healthcare apps, featuring capabilities like patient onboarding, triage, messaging, lab ordering, and appointment scheduling, as well as approval processes and data syncing across systems.

Contact: press@keragonhq.com

View original content:https://www.prnewswire.com/news-releases/keragon-an-ai-powered-automation-platform-for-healthcare-launches-out-of-stealth-with-3-million-backing-from-lifepoint-health-302162343.html

SOURCE Keragon

Staff

Recent Posts

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

20 hours ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

20 hours ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

20 hours ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

20 hours ago

Enzon Announces Commencement of Exchange Offer Relating to Series C Non-Convertible Redeemable Preferred Stock in Connection With Viskase Merger

CRANFORD, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Enzon Pharmaceuticals, Inc. (OTCQB: ENZN) (“Enzon” or…

20 hours ago

Park Dental Partners Announces Dates for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading…

20 hours ago